Unlike many other global pharmaceutical giants choosing to divest and spin-off units, Bristol Myers Squibb (BMS) is aggressively expanding its pipeline through open innovation and strategic acquisitions.As a leading biopharma company, BMS is enhancing its presence across multiple therapeutic areas,
OliX Pharmaceuticals, a Korean biotech firm specializing in RNA interference technologies, recently announced the promising results of its hair loss treatment, OLX104C, at the 13th World Congress for Hair Research (WCHR 2024) held in Texas, the U.S. from April 6-9.The WCHR, hosted by the Internation
A technology that sequentially releases antibiotics and growth agents to enhance bone regeneration has been developed by a collaborative research team from Yonsei University.Patients suffering from chronic inflammatory bone diseases such as periodontal disease or osteoporosis experience slow bone re
Samsung Bioepis has achieved a significant milestone by obtaining the first domestic approval for a biosimilar referencing Janssen's Stelara, Epyztek (ingredient: ustekinumab), on Thursday.Stelara, originally developed by Janssen, is utilized in the treatment of plaque psoriasis, psoriatic arthritis
Celltrion said Yuflyma (ingredient: adalimumab), a biosimilar referencing Humira, has been included in the formulary of one of the top three pharmacy benefit managers (PBMs) in the U.S. The three largest PBMs in the U.S., which include CVS Health, Express Scripts, and Optum, collectively manage abou
NKMAX, a local biotech firm specializing in NK cell therapy, announced plans to file an objection to its potential delisting from the Korea Exchange (KRX).The company, which has been listed on the Kosdaq since August 2018, is facing delisting due to significant operational challenges.On March 5, NKM
A research team at the Seoul National University Bundang Hospital (SNUBH) developed an artificial intelligence (AI) model that significantly improves the prediction of mortality rates in patients undergoing extracorporeal membrane oxygenation (ECMO), the hospital said.ECMO, a critical life-support s
Kakao Healthcare said it was invited to speak at the Google Cloud Next 2024 Conference.Google Cloud Next Conference, which is currently being held from Tuesday to Thursday (local time) in Las Vegas, U.S., is an annual tech conference hosted by Google Cloud.During the conference, Kakao Healthcare par
Recent advancements in HIV treatment and prevention, including the roll-out of pre-exposure prophylaxis (PrEP) and the bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) treatment regimen, have highlighted the critical need for ethnic-centered approaches in healthcare.Therefore, understanding
Watson & Company's mental wellness electroceutical tool, Pocus, is receiving attention from industry watchers and the public after showcasing its potential at the 2022 Hangzhou Asian Games, where athletes used it to manage stress and improve sleep quality.Pocus is a wearable device that applies neur
Curocell, a local chimeric antigen receptor-T (CAR-T) developer, said it will start developing a next-generation Anti-CD19 CAR-T therapy for treatment-resistant systemic lupus erythematosus (SLE) as part of the2024 Multi-Ministerial Regenerative Medicine Technology Development Program.This initiativ
Daewoong Pharmaceutical said that it applied for product approval for Envlo, the first homegrown sodium-glucose cotransporter 2 (SGLT2) diabetes drug in Korea and the nation's 36th newly developed drug, to Mexico's Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).COFEPRIS is
The Korea Exchange (KRX) has suspended stock trading of EONE-Diagnomics Genome Center (EDGC), a Kosdaq-listed genomic analysis company, due to unverified rumors that the company received a disclaimer of opinion during its audit process.The suspension took effect when the market opened Monday, with K
Seegene, a Korean in vitro diagnostics company, recently hosted Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), at its headquarters in Songpa-gu, Seoul.The visit, which took place on March 27, served as a platform for both parties to discuss innovative strategies to create a
Lunit said it published a study showing that using Lunit Insight MMG, its AI image analysis solution for mammography, can increase the likelihood of early breast cancer diagnosis and significantly reduce the workload of physicians.The study, conducted in collaboration with researchers from various u
EuBiologics, a Korean vaccine maker targeting the global public health market, said it opened a new office at the Cambridge Innovation Center (CIC) in Boston, one of the largest biotech clusters in the world.EuBiologics' new office opening comes after their selection by KHIDI (Korea Health Industry
A team at Severance Hospital found that stereotactic ablative radiotherapy (SABR) was effective in treating patients with limited metastatic liver cancer.Limited metastatic cancer is defined by the early stage of cancer spread, where metastasis is confined to five or fewer organs.This condition nece
In a move signaling a potential resolution to ongoing family disputes, Hanmi Science, the holding company of Hanmi Pharm, announced the appointment of Lim Jong-hoon as co-CEO alongside the current chairperson, Song Young-sook.The decision came during a board meeting held at Hanmi headquarters in Son
Celltrion has embarked on a partnership with the Crohn's & Colitis Foundation (CCF), the largest patient advocacy group for inflammatory bowel disease (IBD) in the U.S., aiming to boost awareness and improve perceptions of IBD, a chronic inflammatory condition of the gastrointestinal tract.The CCF,
Samsung Bioepis said it has commenced global phase 3 clinical trials for its biosimilar, SB27, a biosimilar referencing Keytruda, a blockbuster cancer treatment developed by MSD.SB27 marks the company's eleventh biosimilar pipeline, illustrating its ongoing commitment to expanding its portfolio in t